- Home
- EDIT vs CLNE Comparison
EDIT vs CLNE Comparison
Compare EDIT & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EDIT | CLNE |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.8M | 500.3M |
| IPO Year | 2016 | 2006 |
Fundamental Metrics
Financial Performance| Metric | EDIT | CLNE |
|---|---|---|
| Price | $2.79 | $1.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $5.30 | $3.32 |
| AVG Volume (30 Days) | ★ 2.7M | 1.4M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $31,937,000.00 | ★ $341,599,000.00 |
| Revenue This Year | N/A | $1.13 |
| Revenue Next Year | N/A | $22.65 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 132.64 | N/A |
| 52 Week Low | $1.66 | $1.66 |
| 52 Week High | $4.54 | $3.11 |
Technical Indicators
Market Signals| Indicator | EDIT | CLNE |
|---|---|---|
| Relative Strength Index (RSI) | 51.01 | 42.53 |
| Support Level | $2.77 | N/A |
| Resistance Level | $3.27 | $2.40 |
| Average True Range (ATR) | 0.20 | 0.08 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 70.16 | 52.70 |
Price Performance
Historical ComparisonAbout EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
About CLNE Clean Energy Fuels Corp.
Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas and liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The firm operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. It also builds, operates, and maintains natural gas fueling stations for customers.